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Pain is an unpleasant sensory or emotional experience associated with tissue 
damage or the potential for tissue damage. Over the years, research has studied the 
relationship between pain and body composition (BC). PURPOSE: The purposes of this 
study were to investigate if there are any site specific differences in pressure pain 
threshold (PPT), if lean and fat mass correlate with PPT values in any way, and if the 
magnitude of a conditioned pain modulation (CPM) or exercise induced hypoalgesia 
(EIH) is affected by BC. METHODS: 30 female and 26 male participants 3 experimental 
visits. BC via DXA scans and muscle/fat thickness at the specific sites were assessed on 
the first visit. During the first visit, participants were also familiarized to the PPT 
protocol. The second visit consisted on a baseline PPT measurement followed by a CPM 
where participants placed their feet in an ice bath for 1 min. Once the CPM protocol was 
completed, PPTs were measured immediately after. Baseline PPTs were measured again 
for the third visit, followed by an EIH protocol. To produce and EIH response, 
participants held 25% of their maximal isometric knee extension till failure. PPTs were 
assessed immediately after exercise failure.  A Spearman correlation coefficients were 
determined between BC values and baseline PPTs. Independent t-test was used to 
determine any gender differences, and a mixed factorial ANOVA was ran for CPM and 
EIH assessments. RESULTS: PPTs from the left forearm (LA) had no significant 
correlations for total body fat (p = 0.85), body fat percentage (p = 0.20), fat percentage 
within the limb (p = 0.73), fat mass within the limb (p = 0.08), fat thickness at the 
measured site (p = 0.59), or skin fold measurements at the site (p = 0.71). No significant 
relationship was found in the right forearm (RA) [total body fat (p = 0.81), body fat 
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percentage (p = 0.24), fat percentage within the limb (p = 0.52), fat mass within the limb 
(p = 0.83), fat thickness at the measured site (p = 0.63), or skin fold measurements (p = 
0.62)] or the non-dominant leg (NDL) [total body fat (p = 0.07), body fat percentage (p = 
0.32), fat mass within the limb (p = 0.33), fat thickness at the site (p = 0.33), or skin fold 
measurements (p = 0.50).The dominant limb’s (DL) PPT did show a significant negative 
correlation with fat percentage within the limb (p = 0.03). The DL did not correlate with 
total body fat (p = 0.90), body fat percentage (p = 0.104), fat mass within the limb (p = 
0.42), fat thickness at the measured site (p=0.08), or skin fold measurements (p = 0.29). 
LA and NDL had significant correlations with total bone free lean mass (LA: p = 0.02, 
NDL: p ≤ 0.001), bone free lean mass at the limb (LA: p = 0.02, NDL: p ≤ 0.001), and 
muscle thickness (LA: p = 0.03, NDL: p = 0.026). The DL had significant correlations for 
total bone free lean mass (p ≤ 0.001) and bone free lean mass at the limb (p ≤ 0.001), but 
not for muscle thickness (p = 0.13). The RA showed significant correlations with bone 
free lean mass at the limb (p = 0.04), but not total bone free lean mass (p = 0.09) or 
muscle thickness (p = 0.26). There were no significant correlations between any of the 
BC measurements and the magnitude of CPM response (p > 0.05). The EIH response 
significantly increased PPTs for all of the four measured sites (p ≤ 0.001). The EIH 
responses did not correlate with any of the taken BC measurements for the LA or the DL 
(p ≥ 0.05). The RA had a significant correlation with total body fat (p = 0.04), fat mass 
within the limb (p = 0.03), and skinfold measurements (p = 0.03); However, all other RA 
BC measurement did not (p ≥ 0.05). No measures of BC correlated with the EIH response 
for the NDL (p ≥ 0.10). The EIH responses for the NDL did not correlate with total bone 
free lean mass or bone free lean mass with in the limb (p ≥ 0.05).  The results did show 
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that the NDL muscle thickness was negatively correlated with the EIH response (p = 
0.04). CONCLUSION: PPTs positively correlated with bone free lean mass and not fat 
mass, suggesting that bone free lean mass plays a role in individuals PPTs values. The 
CPM response showed no relationship with BC. Results did suggest a potential 
relationship between the EIH response and BC; however, further investigation is need to 
determine if a relationship exists. 
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Chapter I: Introduction 
1.1: Introduction 
Pain is an unpleasant sensory or emotional experience associated with tissue 
damage or the potential for tissue damage (Merskey & Bogduk, 1994). A study published 
in 2012 found that 100 million people in the United States were affected by persistent 
pain, and the annual health care cost of pain was roughly $600 billion (Gaskin & Richard, 
2012). The annual cost of pain was found to be higher than the next six most costly 
diagnoses, with cardiovascular diseases costing the next highest at $309 billion per year 
(Gaskin & Richard, 2012). Individuals with moderate or severe pain spend ($4,000 or 
$7,000, respectively) more per year than individuals with no pain (Gaskin & Richard, 
2012).  
Pain is a complex sensation that aids in avoiding situations where tissue damage 
could occur and to help maintain homeostasis in the body (Christopher D Black, 2012; 
O'Connor & Cook, 1999). Psychological and physiological processes are both involved in 
the perception of pain (Christopher D Black, 2012; O'Connor & Cook, 1999). Pain is the 
brain's interpretation of sensory input, within the somatic nervous system, that are evoked 
by noxious stimuli (Gold & Gebhart, 2010). A noxious stimulus is a stimulus that is 
damaging or potentially damaging to the tissue where the stimulus is applied (O'Connor 
& Cook, 1999). The term nociception describes the activation, conduction, and 
transmission processes for nociceptors to a noxious stimulus (Gold & Gebhart, 2010). 
The two major types of nociceptors are A-delta fibers and C-fibers. A-delta fibers 
typically respond to pressure stimuli and C-fibers typically respond to electrical, thermal, 
and/or chemical stimuli; however, some nociceptors are polymodal—meaning they can 
2 
 
respond to multiple stimuli (Christopher D Black, 2012; O'Connor & Cook, 1999). A-
delta fibers are thinly myelinated free nerve endings and typically have higher conduction 
velocities, while C-fibers are unmyelinated and have lower conductions velocities 
compared to the A-delta fibers (Black, 2012; Gold & Gebhart, 2010). When a noxious 
stimulus interacts with a nociceptor an electrical signal is generated. If the stimulus meets 
or exceeds the activation threshold for the nociceptor, the signal travels down the neuron 
to the dorsal horn of the spinal cord and then travels to different regions of the brain via 
interneurons and several spinal tracts (Gold & Gebhart, 2010)(O'Connor & Cook, 1999). 
A common method used to investigate nociception and pain sensitivity is to determine 
the minimum noxious stimulus required to be deemed “painful”; termed a pain threshold 
(Christopher D Black, 2012; O'Connor & Cook, 1999). Pain thresholds have been shown 
to vary widely among individuals due to factors such as sex, pain history, state-of-
training, etc. (Naugle, Fillingim, & Riley, 2012) Sensitivity to pressure is one of the most 
common noxious stimuli whose threshold is examined—whereby an increasing amount 
of pressure is applied to a specific site until the pressure is painful, termed a pressure pain 
threshold (PPT) (O'Connor & Cook, 1999). Pain thresholds can also be assessed by 
applying either an electrical or thermal noxious stimulus—termed as electrical pain 
threshold (EPT) or thermal pain threshold (TPT) (O'Connor & Cook, 1999). 
One emerging factor that has been shown to potentially influence pain thresholds 
is body composition (BC), specifically excess body fat. The results of previous research 
have varied when investigating the effects of BC on pain thresholds. This may, in part, be 
due to the methods used to assess BC. Body mass index (BMI) (Khimich, 1997; 
McKendall & Haier, 1983; Price, Asenjo, Christou, Backman, & Schweinhardt, 2013; 
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Tashani, Astita, Sharp, & Johnson, 2017; Zahorska-Markiewicz, Kucio, & Pyszkowska, 
1983; Zahorska-Markiewicz, Zych, & Kucio, 1988) and waist-to-hip ratio (WHR) 
(Tashani et al., 2017), neither of which are true measures of BC, skinfold estimates 
(Tashani et al., 2017), and dual-energy x-ray scans (DXA) (Stolzman & Hoeger Bement, 
2016) have all been used to estimate BC and/or body size. When pain thresholds were 
measured at the forearm to an electrical stimulus (Zahorska-Markiewicz et al., 1983, 
1988) or pressure (Khimich, 1997), the results indicated that obese individuals (BMI > 
30) were less sensitive to pain (i.e. have higher pain thresholds) compared to those 
classified as overweight or normal weight. When measured at the hand, obese individuals 
been shown to have either reduced PPTs (more sensitive to pain) or not differ among 
from overweight or normal weight individuals (McKendall & Haier, 1983; Price et al., 
2013; Tashani et al., 2017). The single study that used DXA scans (Stolzman & Hoeger 
Bement, 2016) to objectively measure BC found no difference in PPT values assessed at 
the finger, nailbed, and deltoid muscle across different body composition categories. In a 
previous study from our lab (C. D. Black et al., 2017) and from unpublished observations 
from our lab (Schubert, 2017), we have observed an inverse relationship between body 
weight and PPT in the muscles of the forearm and quadriceps. As such it remains unclear 
the extent to which fat mass, fat-free mass, and/or adipose tissue thickness directly over 
the PPT assessment site affect pain sensitivity particularly to pressure stimuli.   
Exercise-induced hypoalgesia (EIH) is a type of endogenous pain modulation 
where pain sensitivity is acutely decreased following a bout of exercise. EIH has been 
shown to occur in both the exercising limb(s) and at more distant/remote sites on the 
body (Crombie, Brellenthin, Hillard, & Koltyn, 2017; Koltyn & Umeda, 2007). EIH 
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occurs after aerobic, resistance, or isometric exercise and has been shown to last for up to 
30 minutes (Crombie et al., 2017; Koltyn & Umeda, 2007; Vaegter, Handberg, & 
Graven-Nielsen, 2014). The exercises result in an EIH response from activation of 
endogenous pain inhibitory mechanisms, but the pathways that lead to pain this 
modulation are not entirely understood (Koltyn & Umeda, 2007).  The endogenous 
opioid system is a suggested mechanism of EIH and is potentially activated by muscle 
contractions simulating the release of endogenous opioids. The endocannabinoid system 
is another potential mechanism of EIH (Crombie et al., 2017). Cannabinoid levels have 
been shown to rise during exercise and potentially interact with receptors in the brain to 
alter pain interpretations. Another possible mechanism for EIH is a phenomenon method 
termed conditioned pain modulation (CPM). CPM describes a process whereby the 
application of an initial painful stimulus (termed the conditioning stimulus) functions to 
reduce pain from a second stimulus (Ellingson, Koltyn, Kim, & Cook, 2014). This 
process is often termed “pain inhibits pain” and likely works by activating descending 
neural pathways that decrease the pain sensitivity to other applied noxious stimuli 
(Ellingson et al., 2014; Lemley, Hunter, & Bement, 2015). In this manner, pain 
experienced during exercise may function to “condition” the nervous system to future 
noxious stimuli. The magnitude of CPM has been shown to correlate with the magnitude 
of EIH (Lemley et al., 2015), suggesting they may function via similar mechanisms. The 
CPM response is often tested, independently of EIH, by placing a participant’s hand or 
foot into an ice bath for up to a minute and then assess the change in their pain 
sensitivity. Interestingly, DXA assessed bone free lean mass (but not fat mass) has been 
shown to be positively correlated with the CPM response in adolescents—suggesting 
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body composition might plausibly affect the EIH response as well (Stolzman & Hoeger 
Bement, 2016). To the author’s knowledge, no research has been performed to comparing 
whole-body and site-specific body composition with pain sensitivity, EIH, and CPM in 
college-aged adults.  
1.2: Purpose of the Study: 
 The purpose of this study was to determine if a significant relationship exists 
between the sensitivity of several sites to pressure stimuli (assessed as PPTs) were related 
values with DXA assessed measure of body composition and site specific assessments of 
fat and muscle thickness. This study also sought to determine if a significant relationship 
existed for CPM and EIH with body composition measurements. 
1.3: Research Questions 
1. Will a significant relationship exist among resting pressure pain thresholds, assessed 
in both forearms and both quadriceps, and assessments of total body percent fat (via 
DXA), total body fat mass (via DXA), total body lean tissue mass (via DXA), 
assessment site specific fat thickness (via ultrasound), muscle thickness (via 
ultrasound), and site specific skinfold thickness? 
2. Will a significant relationship exist among the conditioned pain modulation response, 
assessed in both forearms and both quadriceps, and assessments of total body percent 
fat (via DXA), total body fat mass (via DXA), total body lean tissue mass (via DXA), 
assessment site specific fat thickness (via ultrasound), muscle thickness (via 
ultrasound), and site specific skinfold thickness? 
3. Will a significant relationship exist among the exercise-induced hypoalgesia 
response, assessed in both forearms and both quadriceps, and assessments of total 
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body percent fat (via DXA), total body fat mass (via DXA), total body lean tissue 
mass (via DXA), assessment site specific fat thickness (via ultrasound), muscle 
thickness (via ultrasound), and site specific skinfold thickness? 
1.4: Sub-Questions 
1. Do resting PPT, CPM, and EIH differ between men and women? 
2. Does a relationship exist among PPT, CPM, EIH, and self-reported physical activity? 
1.5: Hypotheses 
1. A significant positive relationship will exist between resting PPT in both forearms 
and quadriceps and total body percent fat, fat mass, fat thickness, and skinfold 
thickness. 
2. No significant relationship will exist between resting PPT in both forearms and 
quadriceps and lean tissue mass and muscle thickness. 
3. A significant negative relationship will exist between CPM in both forearms and 
quadriceps and total body percent fat, fat mass, fat thickness, and skinfold thickness. 
4. A significant positive relationship will exist between CPM in both forearms and 
quadriceps and lean tissue mass and muscle thickness. 
5. A significant negative relationship will exist between EIH in both forearms and 
quadriceps and total body percent fat, fat mass, fat thickness, and skinfold thickness. 
6. A significant positive relationship will exist between EIH in both forearms and 







1. Women will have reduced resting PPTs compared to men 
2. No differences will be observed between men and women in their CPM and EIH 
response. 
3. A significant positive relationship will exist among resting PPTs, CPM, and EIH and 
total, moderate, and vigorous intensity physical activity. 
1.7: Significance of the Study 
 Based on the author’s knowledge, no research has looked at EIH and its 
relationship with BC; furthermore, CPM and its relationship with BC has only been 
studied in adolescents. This will be the first study that looks into the relationship between 
BC and both EIH and CPM in healthy adults. 
1.8: Limitations 
1. Participants will be between the ages of 18-30 with no prior medically diagnosed 
chronic pain and will be recruited within Norman, OK.  
2. PPTs are subjective and cannot control for dishonest readings. 
3. Participants will be asked to refrain from taking pain medication during the 
experiment, but the daily routines of the participants cannot be controlled. 
1.9: Delimitations 
1. Participants will be familiarized to PPT measurements, MVC protocols, and the EIH 
protocol to limit training effects. 






1. Subjects are without any symptoms of chronic pain. 
2. Subjects are honest on the perception of the onset of pain. 
3. Subjects will give maximal effort during MVC protocols. 
4. The exercise protocol and method used for EIH and CPM are sufficient to produce 
the desired response. 
1.11: Operational Definitions 
1. Algesia: Sensitivity to noxious stimuli. 
2. Hypoalgesia: A decrease in the perception of pain from noxious stimuli. 
3. Exercise-induced hypoalgesia: A decrease in the perception of pain from noxious 
stimuli following a bout of exercise. 
4. Conditioned pain modulation: A decrease in pain sensitivity to noxious stimuli by 
administering noxious stimuli to separate locations 
5. Physical activity: Body movement that requires additional caloric expenditure 
6. Body fat percentage: The percentage of total body composition that is fat. 
7. Total body fat mass: The total amount of fat mass within an individual. 
8. Total body lean tissue mass: The total amount of lean muscle mass within an 
individual.  
9. Muscle thickness: The amount of muscle between the subcutaneous fat and bone at a 
given site. 




11. Skin-fold thickness: The width of subcutaneous fat and skin when measured by 
calipers. 





Chapter II: Review of Literature 
2.1: Nociception 
 Pain, and the unique characteristics it has compared to the other 5 senses, has 
been studied quite frequently and thoroughly. As mentioned previously in chapter 1, the 
term nociception is used when describing a noxious stimulus and the pathways involved 
in the interpretation of the noxious stimulus to be painful. It is very important to 
remember that pain involves both physiological and mental interpretations following a 
noxious stimulus. Tracey and Mantyh (Tracey & Mantyh, 2007)discussed how 
emotion/mood, context, and cognitive awareness can affect the overall interpretation of a 
noxious stimulus, not just the physiological pathways used in a noxious interpretation. 
They concluded that the mental aspect of interpreting pain affects the descending neural 
pathway via different areas within the brain. The authors found evidence showing some 
areas of the brain either facilitate or inhibit nociception; furthermore, those areas of the 
brain are: periaqueductal gray, amygdala, frontal lobe, insula, hypothalamus, anterior 
cingulate cortex, nucleus cuneiformis, and the rostral ventromedial medulla. 
On the more physiological aspect of nociception, multitude of research has 
identified mechanisms for both input and output signaling of pain [see (Christopher D 
Black, 2012; O'Connor & Cook, 1999) for review]. When a stimulus is applied to the 
muscle, it must reach a certain threshold to activate the nociceptors (either A-delta or C 
fibers). Once the fibers are activated, they transmit the signal to the dorsal root of the 
spinal cord where the signal is then transmitted (usually with the biochemical marker 
substance P) to the dorsal horn of the spinal cord. The signal will then travel to the 
supraspinal regions in the brain/brainstem for further interpretation where the above-
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mentioned areas of the brain interact with the signal to affect the descending pathway 
through endogenous opioids; however, modulation of pain is not limited to the 
descending pathway alone. Black (2012) discussed the gate control theory that utilizes 
the activation of non-nociceptive fibers that act to diminish a noxious stimulus by 
inhibition of substance P in the spinal cord via interneurons (i.e. muscle massages).  
Not only is the interpretation process of pain a complex system, but research has 
also shown the gender and age can influence pain sensitivity. Petrini et al. (Petrini, 
Matthiesen, & Arendt-Nielsen, 2015) published a study in 2015 that investigated the 
relationship between both age and gender and their potential effects on PPT values. 20 
young adults (10 female) between the ages of 20-34 and 20 older adults (10 female) 
between the ages of 65-88 participated. All subjects were free from any diagnosed 
chronic pain and reported they were pain-free on the day of the experiment. A hand-held 
pressure algometer was placed on the left and right index fingers and the left and right 
trapezius muscles to measure PPT and pressure pain tolerance threshold (PPTT) (the 
point at which the pain is unbearable). The authors found PPT to be lower in older adults 
compared to younger adults. They concluded the reasons for their results were potentially 
reductions in endogenous pain inhibition and/or degenerative changes due to aging. 
Petrini et al. (Petrini et al., 2015) found gender differences in PPT only in the younger 
adults; furthermore, they concluded the differences could be due to biological, hormonal, 
or genetic factors. A review article by Riley et al. (Riley, Robinson, Wise, Myers, & 





2.2: Exercise-Induced Hypoalgesia 
EIH is a typical intervention to assess PTs, and there are a variety of exercise 
interventions that can produce EIH. Naugle et al published a review comparing various 
aerobic, isometric, and dynamic exercise protocols. The authors concluded that all three 
types of exercise can produce EIH. The responses to the exercise ranged from moderate 
to large depending on the type of exercise as well as duration; more specifically, they 
found isometric exercise to have larger effects when the protocol consisted of low 
intensities (25% of MVC) and longer durations (until failure) (Naugle et al., 2012). 
Hoeger et al. (Hoeger Bement, Dicapo, Rasiarmos, & Hunter, 2008) specifically looked 
at the dose responses for isometric exercises at varying intensities and durations. A total 
of 40 men and women, who were all healthy young adults with no neurological diseases, 
participated in the experiment. All subjects went through a familiarization day followed 
by 4 experimental days; furthermore, all the subjects were administered the same 
interventions. The exercise task was a static contraction of the elbow flexor muscles and 
pain measurements were assessed with a noxious pressure stimulus. The stimulus was 
applied on the middle of the right index finger with a pressure equal to 1 kg and was 
applied for two consecutive minutes. The subjects completed 4 different isometric 
exercises with pain measurements taken before and 30 min after the exercise 
intervention. The 4 exercises were 3 MVCs sustained for 2 secs, holding 25% of MVC 
until task failure, 25% of MVC for 2 min, and 80% of MVC until task failure. Hoeger et 
al found that pain thresholds had the greatest increases following 25% MVC until task 
failure, although the changes in increases were only significant between the two 25% 
exercises and not between task failure exercises (Hoeger Bement et al., 2008). 
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Research has also shown that EIH has a more general pain inhibition and not just 
the exercising muscle group. Kosek and Lundberg (Kosek & Lundberg, 2003) 
investigated the PPT changes in the quadriceps and infraspinatus muscles; furthermore, 
the authors recruited 24 males and females for the experiment. PPTs were measured 
before, during, and 30 min after the exercises. The measurements were taken at the 
exercising muscle, resting contralateral muscle, and resting distal muscle (either the 
quads or infraspinatus muscles) in that order. Subjects were seated in a chair for the 
quadriceps exercise, and they performed a full leg extension using their dominant leg 
with a 1kg weight attached to the ankle; furthermore, the subjects were instructed to hold 
the weight until task failure or until they made it through 10 rounds of PPT assessments. 
For static contractions at the infraspinatus, the subjects were instructed to hold a 0.5kg 
weight attached at the wrist 20 degrees off a pad while keeping the elbow (flexed at 90 
degrees) resting on the pad. The subjects were required to hold that position until task 
failure or until 10 rounds of PPT assessments were completed. The authors found that 
EIH responses can be found not only in the exercising muscle but the contralateral and 
distal muscles as well. The exercising muscle had larger increases in PPTs suggesting 
that there is a localized response as well as a general response to EIH (Kosek & 
Lundberg, 2003). 
A study done by Koltyn et al. (Koltyn, Brellenthin, Cook, Sehgal, & Hillard, 
2014) investigated the mechanisms behind EIH. The authors recruited 30 males and 30 
females to undergo thermal and pressure stimuli to induce a pain response as well as 
complete an isometric exercise protocol to produce EIH. The isometric exercise used a 
hand dynamometer to assess grip strength and required the subjects to hold 25% of their 
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individual MVC for 3 minutes to produce EIH and pain and thermal stimuli were applied 
to the forefinger and the thenar eminence, respectively. All subjects were divided into 
two groups; the control group received a placebo and the experimental group received an 
opioid antagonist pill, which the opioid antagonist would control the potentially 
endogenous opioid response in EIH. The authors also analyzed potential gender 
differences for EIH. The authors found no gender differences for EIH effects. They also 
found that, despite the administered opioid antagonist, a similar EIH response was seen 
for both the control and experimental groups; furthermore, they found an increase in 
circulating endocannabinoid concentrations that would suggest nonopioid mechanisms 
involved in EIH (Koltyn et al., 2014). A study by Crombie et al. (Crombie, Brellenthin, 
Hillard, & Koltyn, 2017) had results that supported Koltyn et al. (Koltyn et al., 2014) 
findings that suggested endocannabinoids to be a major mechanism for EIH and not the 
endogenous opioid response. The results from Crombie et al. (Crombie et al., 2017) 
further suggested that 2-arachidonoylglycerol (2-AG) and 2-oleoylglycerol (2-OG) are 
the primary endocannabinoids responsible for the nonopioid EIH response (Crombie et 
al., 2017). 
2.3: Conditioned Pain Modulation  
 CPM is a highly used intervention when studying algesia and the responses of the 
descending neural pathway from a noxious stimulation. CPM decreases sensitively to a 
noxious stimulus by administering a separate noxious stimulus as a “distraction” 
stimulus.  Due to the requirement of applying a noxious stimulus, research has suggested 
the CPM works through the descending neural pathway via the diffuse noxious inhibitory 
control (DNIC). Lewis et al. (Lewis, Heales, Rice, Rome, & McNair, 2012) even 
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investigated the reliability of certain CPM and found them to be highly reliable for 
investigating endogenous inhibitory pathway and mechanisms. The research shows CPM 
to lead to increases in PT during the administered stimulus and immediately after the 
stimulus is removed. In a methodology review article, Pud et al. (Pud, Granovsky, & 
Yarnitsky, 2009) discussed different ways to induce CPM. The research has yet to 
determine the relationship between the applied noxious conditioning stimulus with the 
testing noxious stimulus due to the varying ways to induce CPM. They determined the 
most common/effective administered noxious stimuli is a cold stimulus (i.e. a foot/hand 
submerged in ice water). The authors also concluded that a standard method needs to be 
developed to control for the varying methods used in the research. Pud et al. (Pud et al., 
2009) published an article suggesting that CPM leads both a homotopic and heterotopic 
pain inhibition. The experiment induced CPM using a cold stimulus applied to the right 
fingers, and pain measurements were taken at both the left and right thenar eminence. 
The authors found decreases in pain sensitivity in both hands immediately after removing 
the cold stimulus. CPM is not to be confused with EIH, although both lead to increases in 
PT (Pud et al., 2009). A study by Vaegter et al.  (Vaegter, Handberg, & Graven-Nielsen, 
2014) investigated the similarities between EIH and CPM. The authors recruited 80 
males and females to undergo CPM via cold stimuli, two aerobic EIH protocols, and 4 
isometric protocol. All EIH protocols had varying intensities and durations and the cold 
stimuli required the subjects to submerge their foot in ice water for the CPM. The authors 
found increases in PT from CPM only happened during the administered cold stimulus, 
and EIH related PT increases had effects lasting 15 min post exercise (Vaegter et al., 
2014). The findings suggest that CPM and EIH use different mechanisms for pain 
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inhibition; furthermore, results from an article by Ellingson et al. (Ellingson et al., 2014) 
supports Vaeger et al. (Vaegter et al., 2014) conclusion comparing EIH and CPM. 
2.4: Body Composition 
BC and its effects on nociception have been slightly investigated over the years 
and has led to very conflicting conclusions. A study (Mckendall & Haier, 1983) 
published in 1982 compared PTs between obese and nonobese subjects. Obesity itself 
was determined to be >130% of a person’s ideal body weight, which was calculated 
based on height and weight. The authors used a pressure stimulus applied to the index 
finger to assess the PT values. They found that obese subjects were more sensitive to the 
stimulus than nonobese. They suggested the endogenous opiate system and its control in 
ingestive behaviors were potential reasons for obese subjects increased sensitivity 
(Mckendall & Haier, 1983). Less than a year later Zahorska et al. (Zahorskamarkiewicz, 
Kucio, & Pyszkowska, 1983) investigated PT values using electrical stimuli on the 
medial surface of the forearm and on the back of the arm; furthermore, only women were 
recruited for the study. This study found obese subjects to be less sensitive to the stimulus 
and also suggested the endogenous opiate system and its increased activity in obesity was 
a potential reason for the differences  (Zahorskamarkiewicz et al., 1983) Zahorska et al 
published another study similar to the previous study, but a 4-week weight loss program 
was administered to half of the obese women. They found the obese group to be less 
sensitive, supporting the previous findings, and the 4-week weight loss program did not 
alter PTs for the obese women (Zahorska-Markiewicz et al., 1988). Khimich (Khimich, 
1997) published an article in 1997 that used an increasing pressure stimulus placed on the 
forearm to assess PTs among 206 subjects. Khimich (Khimich, 1997)found obese 
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subjects to be less sensitive, which supports Zahorska et al’s findings, and offered up the 
idea that obese subjects have a decreased quantity of nerve endings at the skin. In 2013, 
Price et al. (Price, Asenjo, Christou, Backman, & Schweinhardt, 2013) investigated 
thermal PTs in the abdomen, hand, and forehead to compare PT at sites with different 
amounts of excess fat; furthermore, the authors also measured PPTs on the hand and 
forehead. Price et al only found differences in sensitivity at the abdomen and no 
differences were shown for thermal or pressure thresholds at the hand or forehead. The 
authors concluded that PTs in obese subjects are less sensitive to noxious stimuli only at 
sites with higher amounts of excess fat (Price et al., 2013). Stolzman and Bement 
(Stolzman & Hoeger Bement, 2016) investigated the CPM response across different 
weight statuses in adolescents by assessing PPT at the deltoid muscle and nailbed in the 
hand.  They recruited 56 subjects (24 obese/overweight and 37 normal weight) and DXA 
scans were used to better assess BC. The authors had the subjects place their foot in an 
ice water bath for the CPM and pain measurements were assessed while the CPM was 
administered. They found no differences in the PPT responses from the CPM among the 
three weight groups; furthermore, they found that bone free lean mass values at the 
deltoid to be positively associated with CPM and not fat mass values (Stolzman & 
Hoeger Bement, 2016). The most known recent study by Tashani et al. (Tashani, Astita, 
Sharp, & Johnson, 2017) measured thermal and pressure thresholds between obese, 
overweight, and normal subjects. Specifically, PPTs were assessed at the thenar eminence 
since it is a site will little excess fat differences across the three groups. The authors 
found obese subjects to be more sensitive to both the normal and overweight groups and 
18 
 
suggested different body sites will have different responses to noxious stimuli potentially 




Chapter III: Methodology   
3.1: Introduction 
 All participants for this experiment were recruited from the University of 
Oklahoma and the extended area of Norman, OK. A total of 56 participants (30 women; 
26 men), between the ages of 18-30, were recruited for the study. Participants were free 
from injuries and have not been diagnosed with a chronic pain disorder. Females 
confirmed they were not pregnant by completing a pregnancy test, and all included 
female participants were tested during the luteal phase of their menstrual cycle. All 
participants completed a physical activity readiness questionnaire (PAR-Q), the 
international physical activity questionnaire (IPAQ) (Craig et al., 2003), and two 
questionnaires related to pain perception; 1) the Pain Catastrophizing Scale (PCS) 
(Sullivan, Bishop, & Pivik, 1995) and 2) the Pain Attitudes Questionnaire (PAQ) (Yong, 
Gibson, Horne, & Helme, 2001). All participants signed a consent form outlining the 
about the risk, benefits, and duration of the experiment prior to participation. 
3.2: Experimental Design 
 Participants completed a total of 3 testing visits with each visit lasting roughly 30-
40 minutes. Participants were asked to refrain from exercise before each visit and were 
ask to not take any over the counter or prescription pain medication during the study. On 
the first visit, participants completed the PAR-Q, IPAQ, PCS, PAQ, and signed the 
consent form at the start of the visit to determine if they meet eligibility qualifications. 
Female participants then completed a pregnancy test to confirm they were not pregnant. 
Next height and weight, ultrasound assessment of muscle and fat thickness and skinfolds 
measurements were taken at the PPT assessment sites. A whole-body DXA scan was then 
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completed. Finally, participants performed 3 MVCs with their dominant knee extensors 
and two assessments PPT at each assessment site (right and left vastus lateralis and right 
and left brachioradialis) were performed in order to familiarize the participants. During 
the second visit PPTs were initially determined followed by the participants placing their 
foot in an ice bath for 60 seconds. PPTs were then reassessed. During the third and final 
visit, an initial assessment of PPTs was again completed followed by isometric knee 
extension exercise performed at 25% of MVC until task failure. PPTs were then 
immediately re-measured. 
3.3: DXA Scan 
BC was determined with a whole body DXA scan (Lunar Prodigy Advance; GE-
Medical Systems, Madison, WI) and corresponding analysis software (enCore 2011, 
version 13.60, GE-Healthcare, Madison, WI) according to the manufacturer’s 
instructions. The same researcher performed and analyzed all the scans in accordance to 
the standard laboratory protocol. Custom regions of interest (ROI) boxes were draw for 
the four specific sites. The ROI area for the forearms spanned from the olecranon process 
on the ulna to the bottom of the radius. The ROI for the legs followed the inguinal line 
(cutting though the neck of the femur) to the bottom of the femur. Participants lay in a 
supine position with their arms resting against the sides of the body. A block was placed 
between their feet to provide better clarity for thigh composition during the scans. DXA 






3.4: Ultrasound Assessments of Muscle Thickness 
 Muscle and fat thickness for the four sites were determined using ultrasound 
equipment (FF sonic UF-750XT, Fukuda Denshi, Tokyo, JPN). The same researcher 
performed all thickness measurements and analyses for each of the four sites. The probe 
was placed perpendicular to the specific limb and the given image was frozen for further 
analysis. To prevent any compression of muscle or fat, at least 5mm of ultrasound gel 
was visible on the display screen. Muscle thickness was measured from the first onset of 
muscle tissue down to the bone and fat thickness was measured between the skin and first 
layer of muscle of the specific sites. Measurements were taken using the software within 
the ultrasound by drawing a direct line between the composition boundaries and recorded 
in mm. 
 3.5: Assessment of Pressure Pain Thresholds 
An FDIX Force One Pressure Algometer (Wagner Instruments, Greenwich, CT) 
with a 1 cm diameter circular rubber interfaced with Medoc Algomed software (Medoc 
Ltd., Ramat Yishai, Israel) was used to assess PPT. Assessments were performed over the 
belly of the brachioradialis muscle (BR) of both forearms and the belly of both vastus 
lateralis (VL) muscles. Participants were seated in a comfortable chair with their feet flat 
on the ground, with their knees flexed at approximately 90° and their quadriceps relaxed. 
For assessments of BR PPT they remained in the same seated position, but extended their 
arms in front of them and rested it on a solid, flat surface.  Marks were placed 
approximately 1 inch apart over the belly of each muscle to ensure similar algometer 
placement for each assessment throughout the study. Pressure was applied to the muscle 
at a rate of 50 kilopascals (kPa) per second with the algometer placed perpendicular to 
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the assessment site.  Participants indicated when the pressure became painful (defined as 
the point at which the pressure first “hurt”) by pressing a handheld button that stopped 
the data collection software and marked the pressure value. Two trials were performed at 
each assessment site and averaged as the criterion assessment of PPT. The site testing 
order was as follows: the left VL, right VL, right BR, and finally left BR. The order was 
repeated for the second trial. 
To produce EIH, an isometric knee extension exercise protocol was performed 
using the dominant leg. The protocol consisted of a time-to- task failure exercise bout 
performed at 25% of each participant’s MVC. The participants were seated with their 
dominant knee at 110 degrees (full leg extension being 180 degrees) for both the EIH and 
MVC protocols. The ankle of each leg was secured against the end of an immobile lever 
arm, with a force transducer attached perpendicular to the line of pull. The force 
transducer was connected to acknowledge Biopac software and force data were displayed 
and recorded. MVC was assessed by instructing participants to “kick” against the strap 
around their ankle as forcefully as possible while the experimenter provided verbal 
encouragement. Three efforts were completed with two minutes of rest in between each 
attempt; the highest value was used as MVC. During the time-to-task failure exercise 
bout, participants were able to see the required force value by a line marked in the Biopac 
program and participants were asked to contract with a force equal to the mark and 
maintain this force for as long as possible.  
3.6: Statistical Analysis 
 All data were analyzed using SPSS version 24 (IBM Armonk, New York). 
Independent measures t-tests were performed to compared all measured variables for a 
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given arm or leg between men and women. A 2 (men vs women) x 4 (pain testing site; 
dominant leg, non-dominant leg, right arm, left arm) mixed factorial ANOVA was 
performed to examine differences in resting PPTs, CPM, and EIH between men and 
women among the testing sites. Significant interactions were followed up with one-way 
ANOVAs and post-hoc simple comparisons or main comparisons were made using a 
Bonferroni alpha correction. Bivariate relationships among body composition, PPT, 
CPM, EIH, physical activity, and pain attitudes and catastrophizing were examined by 
calculating a Spearman ρ (rho) correlation coefficient to account for non-normal 




Chapter 4: Results 
 A total of 56 (30 women; 26 men) participants completed the study. Table 1 
shows participant characteristics. 
4.1: Gender Differences in Participant Characteristics 
 Men were taller (p = 0.0005) and heavier (p = 0.000004) compared to women. No 
differences were observed in BMI (p = 0.17). Whole body DXA scans revealed women to 
have lower BMD (p = 0.00005) and lean tissue mass (p < 0.00001) as well as high 
percent body fat (p < 0.00001) and fat mass (p = 0.02).  
 
Table 1 – Participant Characteristics by Sex 
Measure 
Female 
(n = 30) 
Male 
(n = 26) 
Total 
(n = 56) 
 
Age (yr) 22.6 ± 2.6 23.3 ± 2.6 22.9 ± 2.6 
Height (cm) 161 ± 28.3* 182 ± 6.1 170.8 ± 23.5 
Weight (kg) 65.8 ± 12* 83.3 ± 13.5 73.9 ± 15.4 
BMI (kg/m2)  23.7 ± 3.7 25.1 ± 3.8 24.3 ± 3.8 
BMD (g/cm2) 1.201 ± 0.101* 1.320 ± 0.097 1.256 ± 0.115 
DXA %Fat (%) 31.6 ± 7.9* 18.2 ± 8.3 25.4 ± 10.5 
DXA Fat Mass (kg) 21.2 ± 8.5* 15.5 ± 9.5 18.5 ± 9.4 
DXA Bone Free Lean Mass (kg) 40.2 ± 9.0* 64.3 ± 10.6 51.4 ± 15.5 
BMI: Body mass index; BMD: Bone mineral density,*indicates a significant difference (P < 
0.05) between female and male participants. Values are mean ± the SD 
 
 Tables 2-5 contain data for site-specific (Table 2 for the dominant leg, Table 3 for 
the Non-dominant leg, Table 4 for the right arm, and Table 5 for the left arm) body 
composition assessed from DXA and ultrasound as well as resting PPTs, CPM, and EIH 
at each site. In each limb women had lower BMD (p < 0.05), higher percent fat (p < 
0.05), larger fat mass (p < 0.05), lower bone free lean mass (p < 0.05), greater 
subcutaneous fat thickness over the PPT site (p < 0.05), lower muscle thickness at the 
PPT site (p < 0.05), and a larger skin-fold thickness at the PPT site (p < 0.05) compared 
25 
 
to men. In the dominant leg, men were stronger (p < 0.0001), but endurance time to task 
failure at 25% of MVC did not differ between men and women (p = 0.97).   
 
 
Table 2 – Dominant leg composition and pain sensitivity by sex 
Measure 
Female 
(n = 30) 
Male 
(n = 26) 
Total 
(n = 56) 
 
Leg BMD (g/cm2) 1.439 ±  0.126* 1.678 ± 0.158 1.550 ± 0.185 
DXA %Fat (%) 42.6 ± 6.9* 24.1 ± 9.5 34.0 ± 12.3 
DXA Fat Mass (kg) 3.7 ± 1.2* 2.5 ± 1.3 3.2 ± 1.4 
DXA Bone Free Lean Mass (kg) 4.9 ± 0.9* 7.7 ± 1.3 6.2 ± 1.8 
US Fat Thickness (mm) 9.8 ± 3.6* 4.1 ± 2.7 7.2 ± 4.3 
US Muscle Thickness (mm) 40.9 ± 7.4* 48.8 ± 8.3 44.6 ± 8.7 
Skin-fold Thickness (mm) 26.8 ± 10.3* 14.2 ± 7.4 21.0 ± 11.0 
Knee Ext MVC (lbs) 66.9 ± 14.3* 102.7 ± 24.1 83.5 ± 26.4 
TTF (sec) 203.4 ± 70.6 204.4 ± 124.4 203.9 ± 98.3 
Resting PPT (kPa) 456.5 ± 193.0* 669.4 ± 244.2 555.3 ± 244.2 
CPM (%) 15.0 ± 16.0 14.9 ± 21.9 15.0 ± 18.8 
EIH (%) 41.8 ± 32.4 34.1 ± 29.2 38.2 ± 30.9 
BMD: Bone mineral density; US: Ultrasound; Knee Ext MVC: Maximal voluntary 
contraction strength of the knee extensors; TTF: Time to task failure when holding 25% of 
MVC; PPT: Pressure pain threshold; CPM: Conditioned pain modulation; EIH: Exercise-
induced hypoalgesia. *indicates a significant difference (P < 0.05) between female and male 
participants. Values are mean ± the SD   
 
Table 3 – Non-dominant leg composition and pain sensitivity by sex 
Measure 
Female 
(n = 30) 
Male 
(n = 26) 
Total 
(n = 56) 
Leg BMD (g/cm2) 1.472 ± 0.123* 1.680 ± 0.133 1.568 ± 0.164 
DXA %Fat (%) 42.3 ± 6.6* 24.6 ± 10.3 34.1 ± 12.3 
DXA Fat Mass (kg) 3.5 ± 1.3* 2.4 ± 1.2 3.0 ± 1.4 
DXA Bone Free Lean Mass (kg) 4.7 ± 1.1* 7.6 ± 1.3 6.0 ± 1.9 
US Fat Thickness (mm) 10.2 ± 3.6* 4.1 ± 3.1 7.4 ± 4.6 
US Muscle Thickness (mm) 38.6 ± 5.8* 46.9 ± 7.6 42.5 ± 7.8 
Skin-fold Thickness (mm) 26.9 ± 9.4* 14.3 ± 8.2 21.0 ± 10.8 
Resting PPT (kPa) 426.1 ± 168.5* 608.0 ±232.0 510.5 ± 218.7 
CPM (%) 21.4 ± 19.4 19.6 ± 12.6 20.5 ± 16.5 
EIH (%) 26.6 ± 22.1* 13.9 ± 23.0 20.7 ± 23.2 
BMD: Bone mineral density; US: Ultrasound; Knee Ext MVC: Maximal voluntary 
contraction strength of the knee extensors; TTF: Time to task failure when holding 25% of 
MVC; PPT: Pressure pain threshold; CPM: Conditioned pain modulation; EIH: Exercise-
induced hypoalgesia. *indicates a significant difference (P < 0.05) between female and 





 A significant sex testing site interaction was found for resting PPT (Figure 1). 
Post-hoc analysis revealed women had lower PPTs at all four testing sites compared to 
men (p ≤ 0.01 fpr each). In both men and women PPTs from the dominant leg were 
higher than the other 3 testing sites (p ≤ 0.008 for each; Figure 1) and PPTs in both arms 
 
 
Table 4 – Right forearm composition and pain sensitivity by sex 
Measure 
Female 
(n = 30) 
Male 
(n = 26) 
Total 
(n = 56) 
Forearm BMD (g/cm2) 0.955 ± 0.126* 1.151 ± 0.124 1.046 ± 0.159 
DXA %Fat (%) 18.1 ± 7.4* 8.1 ± 4.6 13.4 ± 8.0 
DXA Fat Mass (kg) 0.19 ± 0.1* 0.14 ± 0.1 0.17 ± 0.1 
DXA Bone Free Lean Mass (kg) 0.86 ± 0.1* 1.5 ± 0.3 1.2 ± 0.4 
US Fat Thickness (mm) 4.8 ± 1.9* 2.2 ± 1.1 3.6 ± 2.0 
US Muscle Thickness (mm) 20.6 ± 3.3* 26.7 ± 5.8 23.4 ± 5.5 
Skin-fold Thickness (mm) 10.1 ± 3.4* 7.4 ± 3.0 8.9 ± 3.5 
Resting PPT (kPa) 313.5 ± 134.9* 413.6 ± 159.6 359.9 ± 154.0 
CPM (%) 14.1 ± 24.2 14.9 ± 30.2 14.5 ± 26.9 
EIH (%) 17.3 ± 26.3 15.8 ± 21.0 16.6 ± 23.8 
BMD: Bone mineral density; US: Ultrasound; Knee Ext MVC: Maximal voluntary 
contraction strength of the knee extensors; TTF: Time to task failure when holding 25% 
of MVC; PPT: Pressure pain threshold; CPM: Conditioned pain modulation; EIH: 
Exercise-induced hypoalgesia. *indicates a significant difference (P < 0.05) between 
female and male participants. Values are means ± the SD 
Table 5 – Left forearm composition and pain sensitivity by sex 
Measure 
Female 
(n = 30) 
Male 
(n = 26) 
Total 
(n = 56) 
Forearm BMD (g/cm2) 0.961 ± .0116* 1.193 ± 0.191 1.069 ± 0.193 
DXA %Fat (%) 19.1 ± 7.4* 8.2 ± 4.6 14.0 ± 8.3 
DXA Fat Mass (kg) 0.20 ± 0.1* 0.14 ± 0.1 0.17 ± 0.1 
DXA Bone Free Lean Mass (kg) 0.82 ± 0.1* 1.5 ± 0.3 1.1 ± 0.4 
US Fat Thickness (mm) 5.0 ± 2.0* 2.6 ± 1.8 3.8 ± 2.2 
US Muscle Thickness (mm) 20.7 ± 3.6* 27.2 ± 5.8 23.7 ± 5.7 
Skin-fold Thickness (mm) 10.6 ± 3.3* 7.7 ± 3.2 9.2 ± 3.6 
Resting PPT (kPa) 297.7 ± 108.9* 396.3 ± 162.0 343.4 ± 143.7 
CPM (%) 7.5 ± 26.5 11.7 ± 20.7 9.4 ± 23.5 
EIH (%) 20.4 ± 29.4 16.4 ± 24.5 18.6 ± 27.1 
BMD: Bone mineral density; US: Ultrasound; Knee Ext MVC: Maximal voluntary 
contraction strength of the knee extensors; TTF: Time to task failure when holding 25% of 
MVC; PPT: Pressure pain threshold; CPM: Conditioned pain modulation; EIH: Exercise-
induced hypoalgesia. *indicates a significant difference (P < 0.05) between female and male 
participants. Values are means ± the SD 
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were lower than those from both legs (p ≤ 0.001 for each; Figure 1). No differences were 




Figure 1 – Resting pressure pain thresholds across the 4 testing sites in men and women. 
*indicates a significant difference (p < 0.05) between men and women at that site. # 
indicates a significant (p < 0.05) difference in both men and women from the dominant 
leg. † indicates a significant difference from both legs in both men and women (p < 0.05). 
Values are mean ± SD.  
 
 The CPM response among testing sites and men and women are shown in Figure 
2. The sex x testing site interaction was not significant (p = 0.85), nor was there a main 
effect for sex (p = 0.84). A main effect for testing site was found (p = 0.049). Follow-up 
analysis of main comparisons among testing sites revealed the CPM response was 
reduced in the left arm compared to the non-dominant leg (p = 0.023). No other 







Figure 2 – CPM response (change in PPT from pre to post 1 minute of foot immersion in 
an ice bath) across the 4 testing sites in men and women. **indicates a significant 
difference (main comparison; p < 0.05) between testing sites. Values are mean ± SD.  
 
 The EIH response among testing sites and men and women are shown in Figure 3. 
The sex x testing site interaction was not significant (p = 0.48), nor was there a main 
effect for sex (p = 0.23). A main effect for testing site was found (p < 0.001). Follow-up 
analysis of main comparisons among testing sites revealed the EIH response was reduced 
in the non-dominant leg, right and left arms compared to the dominant leg (p < 0.001). 




Figure 3 – EIH response (change in PPT from pre to post isometric exercise with the 
dominant leg) across the 4 testing sites in men and women. **indicates a significant 
difference (main comparison; p < 0.05) from the dominant leg. Values are mean ± SD.  
 
Table 6 contains self-reported data on physical activity, pain catastrophizing, and 
pain attitudes. There were no significant difference between women and men for any 
dimension of the IPAQ (p > 0.10 for each). No differences were observed for any of the 
dimension of the PAQ between women and men as well (p > 0.19 for each). Additionally, 





Table 6 – Self-reported pain characteristics and physical activity by sex 
Measure 
Female 
(n = 30) 
Male 
(n = 26) 
Total 
(n = 56) 
IPAQ Total (MET∙min∙wk-1) 6307.1 ± 5700.8 4826.4 ± 3163.5 5619.6 ± 4715.9 
IPAQ Walking (MET∙min∙wk-1) 1776 ± 1516.2 1146.2 ± 1281.6 1483.6 ± 1435 
IPAQ Moderate (MET∙min∙wk-1) 1542.1 ± 1845.3 1592.8 ± 1536.6 1565.7 ± 1693.9 
IPAQ Vigorous (MET∙min∙wk-1) 3089.1 ± 3998.5 2087.3 ± 1736.8 2624 ± 3171 
Pain Att: Stoic-Fortitude 16.8 ± 3.8 16.1 ± 4.4 16.5 ± 4.1 
Pain Att: Stoic-Concealment 11.8 ± 3.1 11.3 ± 3.1 11.6 ± 3.0 
Pain Att: Stoic-Superiority 14.0 ± 3.4 13.5 ± 3.6 13.8 ± 3.5 
Pain Att: Cautious-Self Doubt 14.6 ± 4.2 13.3 ± 4.0 14.0 ± 4.1 
Pain Att: Cautious-Reluctance 14.1 ± 3.2 13.0 ± 2.8 13.6 ± 3.0 
Pain Catastrophizing 11.6 ± 8.1 13.9 ± 10.4 12.6 ± 9.2 
IPAQ: International physical activity questionnaire; Pain Att: Pain attitudes questionnaire. 
Values are mean ± the SD 
 
4.2: Relationship of Pain Sensitivity and Body Composition  
Spearman’s ρ correlation coefficients can be seen in Table 7. The measurements 
taken at the left forearm (LA) found no significant correlation between PPTs and total 
body fat (p = 0.85), body fat percentage (p = 0.20), fat percentage within the limb (p = 
0.73), fat mass within the limb (p = 0.08), fat thickness at the measured site (p = 0.59), or 
skin fold measurements at the site (p = 0.71). The same results held true for both the right 
forearm (RA) (total body fat (p = 0.81), body fat percentage (p = 0.24), fat percentage 
within the limb (p = 0.52), fat mass within the limb (p = 0.83), fat thickness at the 
measured site (p = 0.63), or skin fold measurements (p = 0.62) and the non-dominant leg 
(NDL) (total body fat (p = 0.07), body fat percentage (p = 0.32), fat mass within the limb 
(p = 0.33), fat thickness at the site (p = 0.33), or skin fold measurements (p = 0.50; Table 
7).The dominant limb’s (DL) PPT did show a significant negative correlation with fat 
percentage within the limb (p = 0.03). The DL did not correlate with the other fat 
measurements [total body fat (p = 0.90), body fat percentage (p = 0.104), fat mass within 
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the limb (p = 0.42), fat thickness at the measured site (p=0.08), or skin fold 
measurements (p = 0.29)]. The Pearson’s correlation coefficients can be seen in Table 7. 
In regards to bone free lean mass composition, the LA and NDL had significant 
correlations with total bone free lean mass (LA: p = 0.02, NDL: p ≤ 0.001), bone free 
lean mass at the limb (LA: p = 0.02, NDL: p ≤ 0.001), and muscle thickness (LA: p = 
0.03, NDL: p = 0.026). The DL had significant correlations for total bone free lean mass 
(p ≤ 0.001) and bone free lean mass at the limb (p ≤ 0.001), but not for muscle thickness 
(p = 0.13). The RA showed significant correlations with bone free lean mass at the limb 
(p = 0.04); However, no significant correlation was found between the RA and total bone 
free lean mass (p = 0.09) or muscle thickness (p = 0.26). 
 There were no significant correlations between any of the BC measurements and 
the magnitude of CPM response (p > 0.05; Table 7). The EIH response significantly 
increased PPTs for all of the four measured sites (p ≤ 0.001). The EIH responses did not 
correlate with any of the taken BC measurements for the LA or the DL (p ≥ 0.05). The 
RA had a significant correlation with total body fat (p = 0.04), fat mass within the limb (p 
= 0.03), and skinfold measurements (p = 0.03); However, no other BC measurement had 
a significant correlation with the RA (p ≥ 0.05). No measures of body composition, in 
regards to fat mass, correlated with the EIH response for the NDL (p ≥ 0.10). The EIH 
responses for the NDL did not correlate with total bone free lean mass or bone free lean 
mass with in the limb (p ≥ 0.05).  The results did show that the NDL muscle thickness 




 Few relationships (shown in Table 8) were found among resting PPTs, CPM, 
EIH, and self-reported physical activity, dimensions of the pain attitudes questionnaire, 
and the pain catastrophizing scale. A positive relationship was found between PCS and 
the dominant leg CPM (p < 0.001), but not with any other pain variable. Stoic fortitude, a 
dimension of the PAQ, was positively correlated with EIH (p < 0.05 for each) in the 
dominant and non-dominant leg, but not in the arms. Stoic superiority was found to 
correlate with EIH in the right arm (p < 0.05), but not at any other site. The only 
significant relationship found among the physical activity data was that vigorous intensity 








Table 7– Relationship among body composition variables and pain sensitivity  
























Weight (kg)     .44**  .05 -.07 |     .49** -.17 -.24 |  .17  .06  .17 |  .24  .18  .08 
BMI (kg/m2)  .22  .10  .02 |    .31* -.07 -.15 | -.03  .10   .27* |  .07  .23  .15 
Tot %Fat -.22  .13  .10 | -.14  .05  .06 | -.16  .06  .21 | -.17  .24  .06 
Tot Fat Mass (kg) -.02  .12  .02 |   .08  .05 -.02 | -.03  .07   .28* | -.03  .26  .09 
Tot Bone Free Lean Mass (kg)     .47** -.04 -.11 |     .45** -.10 -.23 |  .23  .03  .01 |   .30* -.01  .03 
Limb %Fat  -.30*  .15  .16 | -.16 -.02  .04 | -.09  .05  .24 | -.05  .13  .06 
Limb Fat Mass (kg) -.11  .18  .05 |  .04 -.00 -.01 |  .03  .11   .30* |  .08  .21  .05 
Limb Bone Free Lean Mass (kg)     .45**  .01 -.10 |     .43** -.19 -.22 |   .28*  .04 -.01 |   .32*  .00  .05 
Limb Fat Thickness (mm) -.24  .15  .13 | -.13  .02  .10 | -.07  .01  .23 | -.07  .17  .10 
Limb Musc Thickness (mm)  .21  .13 -.23 |   .30* -.03  -.27* |  .15 -.11  .09 |   .30*  .09 -.01 
Limb Skinfold (mm) -.15  .12  .06 | -.09  .10 .13 |  .07  .05   .29* |  .05  .20  .13 
Resting PPT (kPa) -- -.03  .01 | -- -.03 -.04 | -- -.14  .03 | --  .01  .14 
CPM (%)  --  .11 |  --  .05 |  --  .01 |  --  .01 
EIH (%)   -- |   -- |   -- |   -- 
BMI: Body mass index; PPT: Pressure pain threshold; CPM: Conditioned pain modulation; EIH: Exercise-induced 








Table 8 – Relationship among self-reported pain characteristics and physical activity with pain sensitivity  
























PCS  .20       .35** -.02 |  .15 .14 -.12 |  .12 -.08 -.22 |  .07 -.12  .13 
PAQ SF -.08 -.26    .31* | -.06 .18    .30* |   .05 -.04  .25 |  .03 -.03 .00 
PAQ SC -.15  .00 -.08 | -.14 .08 -.07 | -.01  .07 -.06 | -.11  .14 -.19 
PAQ Sup  .13 -.16  .12 |  .19 .26  .08 |  .14  .06    .27* ¤ |  .14  .15  .07 
PAQ CSD .13  .02  .13 |  .15 .12  .02 |  .17  .07 -.10 |  .13  .09  .04 
PAQ CR -.14 -.06  .10 | -.09 .26 -.02 | -.04 -.17  .19 | -.05 -.09  .02 
IPAQ Tot -.04 -.09  .26 |  .00 .05  .18 | -.12  .18  .21 | -.10  .04  .20 
IPAQ Walk -.16 -.13  .20 | -.09 .10  .15 | -.21 -.07  .15 | -.17 -.08  .16 
IPAQ Mod  .06 -.06  .10 |  .03 .02  .09 |  .00  .01  .18 |  .06  .02  .08 
IPAQ Vig -.08  .04   .28* | -.02 .05  .13 | -.08  .21  .21 | -.08  .07  .17 
PCS: Pain Catastrophizing Scale; PAQ: Pain Attitudes Questionnaire; SC: Stoic Fortitude; SC: Stoic Concealment; Sup: Stoic 
Superiority; CSD: Cautious Self Doubt; CR: Cautious Reluctance; IPAQ: International Physical Activity Questionnaire *indicates 








The results from this study suggest that unlike previous findings, total body and 
assessment site specific fat mass/thickness were not related to resting pressure pain 
sensitivity or pain modulatory function assessed via CPM and EIH.  Interestingly, total 
body lean tissue mass and assessment site specific muscle thickness were positively 
correlated with resting PPT. Additionally, self-reported daily physical activity did not 
consistently correlate with resting pressure pain sensitivity or pain modulatory function—
as has sometimes been shown in previous studies. As expected, significant differences 
were observed between men and women, with women exhibiting greater fat reduced 
lean/muscle compared to me, for most body composition measures. Women also 
exhibited lower PPTs at all testing sites compared to men.    
Previous studies that assessed PPTs have found differing results when PPTs are 
compared among BMI groups. Mckendall et al. (1983) and Tashani et al (2017) found 
those classified as obese by BMI were more sensitive to pressure pain compared to 
normal or overweight individuals. However, Price et al (2013) found no differences in 
PPTs among BMI groups and Khimich et al (1997) actually reported obese individuals 
were less sensitive to pressure pain (i.e. had elevated PPTs compared to normal and 
overweight individuals). Our study found BMI did not correlate with resting PPTs at any 
testing site except for the non-dominant leg and only weakly so in the NDL. The 
participants in our study were on average normal based off of BMI, with only a small 
amount in the overweight and the obese categories. Past research had even amounts of 
participants among the three groups, and the lack of participants in the overweight and 
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obese categories in our study could be a potential reason why no significant correlation 
was found.  
 We hypothesized that total body fat percentage and mass as well as site-specific 
fat thickness and skinfold thickness would be positively related to resting PPT, but no 
relationships were found. Rather, our results suggest total body bone free lean mass and 
limb mass and limb muscle thickness were positively related to resting PPTs. Stolzman et 
al (2016) is the only other study, to our knowledge, that used DXA scans to assess BC. 
However, they did not examine the relationship among resting PPT and weight, BMI, or 
any DXA assessed measure of fat and lean tissue, but did not find any differences among 
groups in PPT when compared across BMI categories. Interestingly, the groups did not 
have significant differences in bone free lean mass composition which, based upon our 
results may explain the lack of differences in resting PPT.  
The primary methodological issue/problem with BMI is that is does not account 
for how much fat or bone free lean mass individuals (or groups) have. The majority of 
past research has relied on BMI to classify individuals as obese—making the assumption 
that those with a higher BMI would have more excess fat mass. Tashani et al (2017) 
divided groups based upon BMI, but did use skinfolds to estimate percent body fat and 
found that the obese group did have a higher body fat percentage compared to the normal 
and overweight groups and that the obese exhibited lower PPTs. However, the amount of 
bone free lean mass for the participants was not estimated and therefore it is difficult to 
know if the obese group had a reduced bone free lean mass which might have driven the 
observed decrease in PPT. It is important to note that studies that assessed sensitivity to 
electrical stimuli (EPT) and thermal stimuli (TPT) have shown that fat mass may play a 
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role in pain sensitivity. Two studies that assessed EPT at the forearm found obese 
participants to be less sensitive to than a normal weight group (Zahorska-Markiewicz et 
al 1983, Zahorska-Markiewicz et al 1988). Additionally, Price et al (2013) found that an 
obese group had higher TPTs compared to a normal weight group when TPT was 
assessed on the abdomen (where presumably a higher amount of excess fat was present), 
but no differences were seen when TPTs were taken at the hand (minimal excess fat). 
Electrical and thermal stimuli are primarily sensed by cutaneous type IV nociceptors 
located in and around the skin whereas mechanical pressure preferentially acts on type III 
nociceptors which are often located deeper in skeletal muscle (Christopher D Black, 
2012; O'Connor & Cook, 1999). Because of the differences in receptor location, greater 
subcutaneous fat may alter thermal and electrical sensitivity to a greater extent. Our 
findings that greater lean tissue mass and muscle thickness correlated with resting PPT 
(more muscle equated to higher PPTs) deserves further study. Pain sensitivity tends to 
increase with age and in certain clinical conditions which are often accompanied by loss 
of lean tissue mass.   
This study also found that BC did not affect pain inhibitory function assessed via 
CPM and EIH. To our knowledge only one other study has assessed BC and its effects on 
CPM--Stolzman et al (2016) and no study has examined the effects of BC on the EIH 
response. For CPM Stolzman et al. (2016) found that DXA assessed bone free lean mass 
of the arm predicted 10% of the CPM magnitude response in the deltoid muscle of in 
adolescents. This finding is in contrast to the results of the present study where no 
relationship was observed between the CPM response at any site and any of the measures 
of body composition. The discrepancies for this might be due to the methodologies 
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between studies. Stolzman et al (2016) assessed PPTs while the participants had their in 
the ice bath, while this study assessed PPTs immediately post the ice bath.  The different 
populations that were assessed might also have played a role in the difference responses 
as Stolzman assessed adolescents (12-17.5 years old) while this study tested college-aged 
adults. Perhaps the change(s) in lean tissue mass that typically occur during growth and 
maturation influence the CPM response. This study was the first study to investigate if 
BC affects the EIH response. No moderate-to-large or consistent relationships were found 
between the EIH response at any assessment site and our assessments of BC. A weak 
negative relationship was observed between EIH and muscle thickness in the non-
dominant leg, but this was not observed at any other site. Limb skinfold thickness was 
also weakly correlated to EIH in the right arm, but again this was not found at any other 
testing site. The EIH response has been shown to be reduced with age (Lemley et al., 
2015; Naugle & Riley, 2014) where bone free lean mass often decline with a 
corresponding increase in fat mass—suggesting a possible relationship, but this was not 
borne out in our findings.  
Two other findings from our study are of note. First, it is interesting that the CPM 
and the EIH responses did not correlate as has been shown previously (Lemley et al., 
2015). The study of Lemley et al. (2015) included young and older adults, who showed a 
reduced EIH and CPM response, perhaps aiding in their ability to find a statistical 
relationship. Previous work by Ellingson and colleagues (Ellingson et al., 2014) 
demonstrated that EIH can occur following exercise that is not painful—suggesting they 
may work via similar, but not identical mechanisms. Our findings support this idea. 
Secondly, we found that women exhibited lower PPTs than men. This is a widely 
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reported and consistent finding (Racine et al., 2012; Riley et al., 1998). Considerable 
previous work has focused on the role of estrogen, gender roles, and pain history in the 
observed differences (Racine et al., 2012). Our findings suggest the role of lean tissue 
mass may also contribute to the lower PPTs observed in women. This is an area that has 




Chapter V: Conclusion 
 We concluded that PPTs and its relation to BC is dependent on bone free lean 
mass and not fat mass measurements, which is the novel finding for this study. Higher 
values of total bone free lean mass suggested higher PPTs among the participants. The 
sites measured within each participant with higher bone free lean mass had higher PPTs. 
The hypothesis that fat mass composition positively relates to PPTs was rejected since no 
correlations were shown. Our second hypothesis, pertaining to bone free lean mass, was 
also rejected due to the positive correlations found between bone free lean mass and 
PPTs. We observed both a CPM and EIH response following our applied interventions. 
We did not observe and differences in the magnitude of responses between the varying 
BC measurements. That led us to reject our last hypotheses that fat mass composition 
negatively correlates and that bone free lean mass composition positively correlates with 
the magnitudes of response for CPM and EIH. The biggest limitation to this study is the 
time of day each visit was performed was not controlled for, future studies would benefit 
for controlling for this. Another limitation is the results only apply to noxious pressure 
stimuli and do not address BC and the potential thermal or electrical relationships. It 
would be interesting if future studies sought to assess potential difference for physical 
activity levels. Future studies should utilize more accurate BC measurements (i.e. DXA 
scans) to explore if bone free lean mass or fat mass has any effects on thermal or 
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Appendix B: Consent Form 
 Consent Form 
University of Oklahoma Health Sciences Center (OUHSC)  
University of Oklahoma – Norman Campus 
The Relationship Among Site Specific Fat, Bone free lean mass, and Pressure Pain 
Sensitivity  
Christopher Black, PhD 
 
This is a research study. Research studies involve only individuals who choose to 
participate. Please take your time to make your decision. Discuss this with your family 
and friends. 
 
Why Have I Been Asked To Participate In This Study? 
You are being asked to take part in this study because you are a healthy young adult (18-
30) without any chronic pain. Females: you are not pregnant. 
 
Why Is This Study Being Done? 
The purpose of this study is to compare the relationship between body composition and 
pain sensitivity  
 
How Many People Will Take Part In The Study? 
About 100 people will take part in this study. All visits will take place in the Sensory and 
Muscle Function Laboratory located in the Health and Exercise Science Department on 
the Norman campus.  
 
What Is Involved In The Study? 
If you agree to be in this research, you will be asked to visit the Sensory and Muscle 
Function lab within the Health and Exercise Science Department at the University of 
Oklahoma Norman Campus for 3 separate visits. 
Visit 1: 
 Height, weight, and fat thickness measurements at the forearms and things will be taken. 
Fat thickness will be measured by ultrasound and skinfolds. DXA scans will also be 
taken and participants will provide a urine sample to check hydration status. Female 
participants will complete a pregnancy test before the DXA scans. Pressure pain 
thresholds (PPT) will be assessed at both forearms (brachioradialis muscles) and thighs 
(vastus lateralis muscles) for familiarization on the protocol. Following PPT, participants 
will complete 3 maximal leg extensions on their dominant leg while they are seated and 
their leg in tied in at the ankle. 
Visit 2: 
The second visit, PPT will again be assessed at both forearms and thighs. Participants 
will then place both feet in ice water at 2 degrees Celsius for 1 minute. PPT will be 
assessed immediately after and 15 minutes after the feet are removed from the ice water. 
Visit 3: 
The third visit, PPT will again be assessed at both forearms and thighs. Following the 
PPT assessment, participants will perform a leg extension with their dominant leg, while 
seated with the dominant leg secured at the ankle that is equal to 25% of their maximal 
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effort. Participants will hold that weight for as long as they can. PPT will again be 
assessed immediately after and 15 minutes after the 25% leg extension exercise. 
 
 
How Long Will I Be In The Study? 
We think that you will be in the study for 3 visits, each lasting roughly 30-45 minutes. 
 
There may be anticipated circumstances under which your participation may be 
terminated by the investigator without regard to your consent. 
  
 The researcher feels that it is in your medical best interest. 
 It is deemed risky to test you based upon you’re medical history. 
 You fail to follow study requirements. 
 
You can stop participating in this study at any time. However, if you decide to stop 
participating in the study, we encourage you to talk to the researcher and your regular 
doctor first. 
 
What Are The Risks of The Study?  
If you participate in this research, you will be exposed to radiation from a DXA scan (a 
type of x-ray).  The amount of radiation to which you will be exposed from one DXA 
scan is approximately less than 1% of the amount of radiation that we are exposed to each 
year from natural background sources of radiation. The risk of radiation exposure is 
cumulative over your lifetime. 
 
Performing maximal effort leg extensions may cause some discomfort and the effort 
required to produce maximal force may be uncomfortable. You may experience some 
lightheadedness or nausea. There is also the risk for cardiovascular events when 
performing leg extensions. There may also be some discomfort during the pressure pain 
protocol which may cause some discomfort and possible reddening of the skin. Having 
fee submerged in ice water for extended period of time will lead to temporary discomfort. 
You will be closely monitored for any issues. 
 
Are There Benefits to Taking Part in The Study?  
If you agree to take part in this study, there may or may not be direct medical benefit to 
you. We hope that the information learned from this study will benefit other patients with 
this disease in the future. You will learn your body composition as well as your level of 
sensitivity to pressure pain. 
 
What Other Options Are There? 
You may choose not to participate in the study. 
 
What about Confidentiality? 
Efforts will be made to keep your personal information confidential. You will not be 
identifiable by name or description in any reports or publications about this study. We 
cannot guarantee absolute confidentiality. Your personal information may be disclosed if 
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required by law.  You will be asked to sign a separate authorization form for use or 
sharing of your protected health information. 
 
There are organizations outside the OUHSC that may inspect and/or copy your research 
records for quality assurance and data analysis. These organizations include the US Food 
& Drug Administration and other regulatory agencies. The OUHSC Human Research 
Participant Program office, the OUHSC Institutional Review Board, and the OUHSC 
Office of Compliance may also inspect and/or copy your research records for these 
purposes.  
 
What Are the Costs? 
There is no cost to you if you participate in this study. 
 
Will I Be Paid For Participating in This Study? 
You will be entered in a raffle for a gift card for your participation. 
 
What if I am Injured or Become Ill While Participating in this Study? 
In case of injury or illness resulting from this study, emergency medical treatment is 
available. However, you or your insurance company will be expected to pay the usual 
charge from this treatment. The University of Oklahoma-Norman and the University of 
Oklahoma Health Sciences Center have not set aside any funds to compensate you in the 
event of injury. 
 
What Are My Rights As a Participant? 
Taking part in this study is voluntary.  You may choose not to participate.  Refusal to 
participate will involve no penalty or loss of benefits to which you are otherwise entitled. 
If you agree to participate and then decide against it, you can withdraw for any reason 
and leave the study at any time.  However, at certain times during the treatment, it may be 
harmful for you to withdraw, so please be sure to discuss leaving the study with the 
principal investigator or your regular doctor.  You may discontinue your participation at 
any time without penalty or loss of benefits to which you are otherwise entitled. 
 
We will provide you with any significant new findings developed during the course of the 
research that may affect your health, welfare, or willingness to continue your 
participation in this study.  
 
You have the right to access the medical information that has been collected about you as 
a part of this research study.  However, you may not have access to this medical 
information until the entire research study has completely finished. You consent to this 
temporary restriction. 
 
Whom Do I Call If I have Questions or Problems? 
If you have questions, concerns, or complaints about the study or have a research-related 
injury, contact Cameron Lohman at 580-318-4151 or cameron.l.lohman-1@ou.edu, or 
Christopher Black, PhD at 706-255-3750 or cblack@ou.edu. 
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If you cannot reach the Investigator or wish to speak to someone other than the 
investigator, contact the OUHSC Director, Office of Human Research Participant 
Protection, at 405-271-2045. 
For questions about your rights as a research participant, contact the OUHSC Director, 
Office of Human Research Participant Protection at 405-271-2045. 
 
Signature: 
By signing this form, you are agreeing to participate in this research study under the 
conditions described. You have not given up any of your legal rights or released any 
individual or entity from liability for negligence. You have been given an opportunity to 
ask questions. You will be given a copy of this consent document. 
 
I agree to participate in this study: 
 
_________________________________ _______________________ _________ 
PARTICIPANT SIGNATURE (age >18) Printed Name   Date 
 
_________________________________ _______________________ _________ 








Appendix C: HIPPA 
University of Oklahoma Health Sciences Center Research Privacy Form 1 
PHI Research Authorization 
 
AUTHORIZATION TO USE or SHARE 
HEALTH INFORMATION1 THAT IDENTIFIES YOU FOR RESEARCH 
An Informed Consent Document for Research Participation may also be required. 
Form 2 must be used for research involving psychotherapy notes. 
Title of Research Project: The Relationship Among Site-Specific Fat, Lean Mass, and 
Pressure 
Pain Sensitivity 
Leader of Research Team: Christopher D. Black, PhD 
Address: 1401 Asp Avenue, #110 SFC, Norman, OK, 73019 
Phone Number: 706-255-3750 (cell); 405-325-7668 (office) 
If you decide to sign this document, University of Oklahoma Health Sciences Center 
(OUHSC) researchers may use or share information that identifies you (protected health 
information) for their research. Protected health information will be called PHI in this 
document. 
PHI To Be Used or Shared. Federal law requires that researchers get your permission 
(authorization) to use or share your PHI. If you give permission, the researchers may use 
or share with the people identified in this Authorization any PHI related to this research 
from your medical records and from any test results. Information used or shared may 
include all information relating to any tests, procedures, surveys, or interviews as 
outlined in the consent form; medical records and charts; name, address, telephone 
number, date of birth, race, government-issued identification numbers, and nothing else. 
Purposes for Using or Sharing PHI. If you give permission, the researchers may use 
your PHI to assess pressure pain thresholds among participants with varying body 
compositions to determine the relationship among site-specific fat, bone free lean mass, 
and pressure pain sensitivity. 
Other Use and Sharing of PHI. If you give permission, the researchers may also use 
your PHI to develop new procedures or commercial products. They may share your PHI 
with other researchers, the research sponsor and its agents, the OUHSC Institutional 
Review Board, auditors and inspectors who check the research, and government agencies 
such as the Food and Drug Administration (FDA) and the Department of Health and 
Human Services (HHS), and when required by law. The researchers may also share your 
PHI with your physician and/or a University of Oklahoma physician in the event of a 
serious health risk or adverse event that occurs during the study. 
50 
 
Confidentiality. Although the researchers may report their findings in scientific journals 
or meetings, they will not identify you in their reports. The researchers will try to keep 
your information 
1 Protected Health Information includes all identifiable information relating to any aspect of an 
individual’s health whether past, present or future, created or maintained by a Covered Entity. 
University of Oklahoma Health Sciences Center Research Privacy Form 1 
PHI Research Authorization 
confidential, but confidentiality is not guaranteed. The law does not require everyone 
receiving the information covered by this document to keep it confidential, so they could 
release it to others, and federal law may no longer protect it. 
YOU UNDERSTAND THAT YOUR PROTECTED HEALTH INFORMATION 
MAY INCLUDE INFORMATION REGARDING A COMMUNICABLE OR 
NONCOMMUNICABLE DISEASE. 
Voluntary Choice. The choice to give OUHSC researchers permission to use or share 
your PHI for their research is voluntary. It is completely up to you. No one can force you 
to give permission. However, you must give permission for OUHSC researchers to use or 
share your PHI if you want to participate in the research and, if you cancel your 
authorization, you can no longer participate in this study. 
Refusing to give permission will not affect your ability to get routine treatment or health 
care unrelated to this study from OUHSC. 
Canceling Permission. If you give the OUHSC researchers permission to use or share 
your PHI, you have a right to cancel your permission whenever you want. However, 
canceling your permission will not apply to information that the researchers have already 
used, relied on, or shared or to information necessary to maintain the reliability or 
integrity of this research. 
End of Permission. Unless you cancel it, permission for OUHSC researchers to use or 
share your 
PHI for their research will never end. 
Contacting OUHSC: You may find out if your PHI has been shared, get a copy of your 
PHI, or cancel your permission at any time by writing to: 
Privacy Official or Privacy Board 
University of Oklahoma Health Sciences Center University of Oklahoma Health Sciences 
Center 
PO Box 26901 PO Box 26901 
Oklahoma City, OK 73190 Oklahoma City, OK 73190 
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If you have questions, call: (405) 271-2511 or (405) 271-2045. 
Access to Information. You have the right to access the medical information that has 
been collected about you as a part of this research study. However, you may not have 
access to this medical information until the entire research study is completely finished. 
You consent to this temporary restriction. 
Giving Permission. By signing this form, you give OUHSC and OUHSC’s researchers 
led by the Research Team Leader permission to share your PHI for the research project 
listed at the top of this form. 
University of Oklahoma Health Sciences Center Research Privacy Form 1 
PHI Research Authorization 
Patient/Participant Name (Print): _________________________ 
__________________________________________ _______________ 
Signature of Patient-Participant Date or Parent if Participant is a minor 
Or 
__________________________________________ _______________ 
Signature of Legal Representative** Date 
**If signed by a Legal Representative of the Patient-Participant, provide a description of 
the relationship to the Patient-Participant and the authority to act as Legal Representative: 
______________________________________________________________________ 
OUHSC may ask you to produce evidence of your relationship. 
A signed copy of this form must be given to the Patient-Participant or the Legal 





Appendix D: International Physical Activity Questionnaire 
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
(October 2002) 
 
LONG LAST 7 DAYS SELF-ADMINISTERED FORMAT 
 
 
FOR USE WITH YOUNG AND MIDDLE-AGED ADULTS (15-69 years) 
 
The International Physical Activity Questionnaires (IPAQ) comprises a set of 4 
questionnaires. Long (5 activity domains asked independently) and short (4 generic 
items) versions for use by either telephone or self-administered methods are available. 
The purpose of the questionnaires is to provide common instruments that can be used to 
obtain internationally comparable data on health–related physical activity. 
 
Background on IPAQ 
The development of an international measure for physical activity commenced in 
Geneva in 1998 and was followed by extensive reliability and validity testing undertaken 
across 12 countries (14 sites) during 2000. The final results suggest that these 
measures have acceptable measurement properties for use in many settings and in 
different languages, and are suitable for national population-based prevalence studies of 
participation in physical activity. 
 
Using IPAQ  
Use of the IPAQ instruments for monitoring and research purposes is encouraged. It is 
recommended that no changes be made to the order or wording of the questions as this 
will affect the psychometric properties of the instruments.  
 
Translation from English and Cultural Adaptation 
Translation from English is encouraged to facilitate worldwide use of IPAQ. Information 
on the availability of IPAQ in different languages can be obtained at www.ipaq.ki.se. If a 
new translation is undertaken we highly recommend using the prescribed back 
translation methods available on the IPAQ website. If possible please consider making 
your translated version of IPAQ available to others by contributing it to the IPAQ website. 
Further details on translation and cultural adaptation can be downloaded from the 
website. 
 
Further Developments of IPAQ  
International collaboration on IPAQ is on-going and an International Physical Activity 





More detailed information on the IPAQ process and the research methods used in the 
development of IPAQ instruments is available at www.ipaq.ki.se and Booth, M.L. (2000). 
Assessment of Physical Activity: An International Perspective. Research Quarterly for 
Exercise and Sport, 71 (2): s114-20. Other scientific publications and presentations on 
the use of IPAQ are summarized on the website. 
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as 
part of their everyday lives. The questions will ask you about the time you spent being 
physically active in the last 7 days. Please answer each question even if you do not 
consider yourself to be an active person. Please think about the activities you do at 
work, as part of your house and yard work, to get from place to place, and in your spare 
time for recreation, exercise or sport. 
 
Think about all the vigorous and moderate activities that you did in the last 7 days. 
Vigorous physical activities refer to activities that take hard physical effort and make 
you breathe much harder than normal. Moderate activities refer to activities that take 
moderate physical effort and make you breathe somewhat harder than normal. 
 
PART 1: JOB-RELATED PHYSICAL ACTIVITY 
 
The first section is about your work. This includes paid jobs, farming, volunteer work, 
course work, and any other unpaid work that you did outside your home. Do not include 
unpaid work you might do around your home, like housework, yard work, general 
maintenance, and caring for your family. These are asked in Part 3. 
 




 No                                            Skip to PART 2: TRANSPORTATION 
 
The next questions are about all the physical activity you did in the last 7 days as part of 
your paid or unpaid work. This does not include traveling to and from work. 
 
2.  During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, heavy construction, or climbing up stairs as 
part of your work? Think about only those physical activities that you did for at 
least 10 minutes at a time. 
 




 No vigorous job-related physical activity              Skip to question 4 
 
3. How much time did you usually spend on one of those days doing vigorous 
physical activities as part of your work? 
 
_____ hours per day 
_____ minutes per day 
 
4. Again, think about only those physical activities that you did for at least 10 
minutes at a time. During the last 7 days, on how many days did you do 
moderate physical activities like carrying light loads as part of your work? 
Please do not include walking. 
 
_____ days per week 
 
 No moderate job-related physical activity               Skip to question 6 
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5. How much time did you usually spend on one of those days doing moderate 
physical activities as part of your work? 
 
_____ hours per day 
_____ minutes per day 
 
6. During the last 7 days, on how many days did you walk for at least 10 minutes 
at a time as part of your work? Please do not count any walking you did to 
travel to or from work. 
 
_____ days per week 
 
 No job-related walking              Skip to PART 2: TRANSPORTATION 
 
7. How much time did you usually spend on one of those days walking as part of 
your work? 
 
_____ hours per day 
_____ minutes per day 
 
 
PART 2: TRANSPORTATION PHYSICAL ACTIVITY 
 
These questions are about how you traveled from place to place, including to places like 
work, stores, movies, and so on. 
 
8. During the last 7 days, on how many days did you travel in a motor vehicle like 
a train, bus, car, or tram? 
 
_____ days per week 
 
 No traveling in a motor vehicle                         Skip to question 10 
 
9. How much time did you usually spend on one of those days traveling in a train, 




_____ hours per day 
_____ minutes per day 
 
Now think only about the bicycling and walking you might have done to travel to and 
from work, to do errands, or to go from place to place. 
 
10. During the last 7 days, on how many days did you bicycle for at least 10 
minutes at a time to go from place to place? 
 
_____ days per week 
 
 No bicycling from place to place                  Skip to question 12 
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11. How much time did you usually spend on one of those days to bicycle from 
place to place? 
 
_____ hours per day 
_____ minutes per day 
 
12. During the last 7 days, on how many days did you walk for at least 10 minutes 
at a time to go from place to place? 
 
_____ days per week 
 
 No walking from place to place Skip to PART 3: 
HOUSEWORK, HOUSE 
MAINTENANCE, AND 
CARING FOR FAMILY 
 
13. How much time did you usually spend on one of those days walking from place 
to place? 
 
_____ hours per day 
_____ minutes per day 
 
 
PART 3: HOUSEWORK, HOUSE MAINTENANCE, AND CARING FOR FAMILY 
 
This section is about some of the physical activities you might have done in the last 7 
days in and around your home, like housework, gardening, yard work, general 
maintenance work, and caring for your family. 
 
14. Think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, chopping wood, shoveling snow, or digging in the 
garden or yard? 
 
_____ days per week 
 





15. How much time did you usually spend on one of those days doing vigorous 
physical activities in the garden or yard? 
 
_____ hours per day 
_____ minutes per day 
 
16. Again, think about only those physical activities that you did for at least 10 
minutes at a time. During the last 7 days, on how many days did you do 
moderate activities like carrying light loads, sweeping, washing windows, and 
raking in the garden or yard? 
 
_____ days per week 
 
 No moderate activity in garden or yard                Skip to question 18 
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17. How much time did you usually spend on one of those days doing moderate 
physical activities in the garden or yard? 
 
_____ hours per day 
_____ minutes per day 
 
18. Once again, think about only those physical activities that you did for at least 10 
minutes at a time. During the last 7 days, on how many days did you do 
moderate activities like carrying light loads, washing windows, scrubbing floors 
and sweeping inside your home? 
 
_____ days per week 
 





19. How much time did you usually spend on one of those days doing moderate 
physical activities inside your home? 
 
_____ hours per day 
_____ minutes per day 
 
 
PART 4: RECREATION, SPORT, AND LEISURE-TIME PHYSICAL ACTIVITY 
 
This section is about all the physical activities that you did in the last 7 days solely for 
recreation, sport, exercise or leisure. Please do not include any activities you have 
already mentioned. 
 
20. Not counting any walking you have already mentioned, during the last 7 days, 
on how many days did you walk for at least 10 minutes at a time in your leisure 
time? 
 
_____ days per week 
 
 No walking in leisure time                               Skip to question 22 
 
21. How much time did you usually spend on one of those days walking in your 
leisure time? 
 
_____ hours per day 




22. Think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do vigorous physical 
activities like aerobics, running, fast bicycling, or fast swimming in your leisure 
time? 
 
_____ days per week 
 
 No vigorous activity in leisure time                      Skip to question 24 
 
23. How much time did you usually spend on one of those days doing vigorous 
physical activities in your leisure time? 
 
_____ hours per day 
_____ minutes per day 
 
24. Again, think about only those physical activities that you did for at least 10 
minutes at a time. During the last 7 days, on how many days did you do 
moderate physical activities like bicycling at a regular pace, swimming at a 
regular pace, and doubles tennis in your leisure time? 
 
_____ days per week 
 
 No moderate activity in leisure time Skip to PART 5: TIME 
SPENT SITTING 
 
25. How much time did you usually spend on one of those days doing moderate 
physical activities in your leisure time? 
_____ hours per day 
_____ minutes per day 
 
 
PART 5: TIME SPENT SITTING 
 
The last questions are about the time you spend sitting while at work, at home, while 
doing course work and during leisure time. This may include time spent sitting at a desk, 
visiting friends, reading or sitting or lying down to watch television. Do not include any 
time spent sitting in a motor vehicle that you have already told me about. 
 
26. During the last 7 days, how much time did you usually spend sitting on a 
weekday? 
 
_____ hours per day 
_____ minutes per day 
 





_____ hours per day 
_____ minutes per day 
 
 










Appendix F: Menstrual History Questionnaire 
Department of Health and Exercise Science 
University of Oklahoma 
 





We are asking you to give us as complete a menstrual history as possible.  All information is 
strictly confidential. 
 
Are you pregnant (circle your response) 
 YES- Do not complete the rest of this form 
 NO- Continue to section A. 
 
SECTION A:  CURRENT MENSTRUAL STATUS 
1. Approximately how many menstrual periods have you had during the past 12 months? 
(please circle what months you have had a period. This means from this time last year to the 
present month) 
Jan      Feb      Mar      Apr      May      Jun      Jul      Aug      Sep      Oct      Nov      
Dec 
 
2. What is the usual length of your menstrual cycle (first day of your period to the next 
onset of your period)?  
 
                          ____________days.                    Today is day ___________ of your present 
menstrual cycle. 
 
3. When was the date of the onset of your last period? 
 
4. When do you expect you next period? 
 





How many of these days do you consider “heavy”?_________________days 
 
 
6. Do you take oral contraceptives or any other medication that includes estrogen and/or 
progesterone?   
If yes, how long have you been taking this 
medication?_________________________ 
What is the brand name and dosage of this 
mediation?_________________________ 
Has this medication affected your menstrual cycle (regularity, length and amount of flow)?  




Appendix G: Pain Attitudes Questionnaire 
Participant #:_______ Testing Session:__________ Date:__________ 
Pain Attitudes Questionnaire–Revised 
Instructions 
Rate how much you agree or disagree with each statement below using a 1 
– 5 scale; where 1 is Strongly Disagree and 5 is Strongly Agree. 
1. I take a long time to decide whether a sensation is painful or not 
 1 2 3 4 5 
2. When I am in pain I should keep it to myself 
 1 2 3 4 5 
3. When a sensation is mild, I tend to not trust myself in deciding whether 
it is painful or not 
 1 2 3 4 5 
4. I keep a stiff upper lip when I am in pain 
 1 2 3 4 5 
5. I lack confidence in making judgments about whether a sensation is 
painful or not 
 1 2 3 4 5 
6. I think I can tolerate more pain than other people 
 1 2 3 4 5 
7. I need time to decide whether a sensation is painful or not 
 1 2 3 4 5 
8. I would rather not make a decision about pain when it is difficult to 
decide whether a sensation is painful or not 
 1 2 3 4 5 
9. I think I can control my pain better than other people 
 1 2 3 4 5 
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10. I avoid making a decision about pain when I am not sure whether a 
sensation is considered painful or not 
 1 2 3 4 5 
11. I take great care to avoid labelling a sensation as painful unless I am 
very certain 
 1 2 3 4 5 
12. When I get odd sensations, I don't necessarily think they are painful 
1 2 3 4 5 
13. I tend to be reluctant to label a sensation as painful unless I am very 
certain 
1 2 3 4 5 
14. I am seldom emotional when in pain 
1 2 3 4 5 
15. I do not see any good in complaining when I am in pain 
1 2 3 4 5 
16. I go on as if nothing has happened when I am in pain 
1 2 3 4 5 
17. I maintain my pride and keep a stiff upper lip when I am in pain 
1 2 3 4 5 
18. I have good control over my pain compared to others 
1 2 3 4 5 
19. I make light of pain; I refuse to get too serious about it when in pain 
1 2 3 4 5 
20. Relative to other people, I am not as emotional when in pain 
1 2 3 4 5 
21. I get on with life despite being in pain 
1 2 3 4 5 
22. I hide my pain from others 
1 2 3 4 5 
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23. I think I can endure more pain than other people 
1 2 3 4 5 
24. I need to be absolutely certain a sensation is painful before I will label 
it as painful 









Appendix I: Email Recruitment Script 
Email Recruitment 
To whom it may concern, 
Hello, my name is Cameron Lohman and I am a Masters student in the Department of 
Health and Exercise Science. Dr. Chris Black and I are looking for research participants 
for a study titled: The Relationship Among Site-Specific Fat, Lean Mass and Pressure 
Pain Sensitivity. We are conducting research looking at the relationship between body 
composition and pain thresholds. If you are between the ages of 18-30, we encourage you 
to participate. 
Participation in this research includes completing the Physical Activity Readiness 
Questionnaire (PAR-Q), the International Physical Activity Questionnaire (IPAQ), and 
an informed consent, which will take 30-45 minutes. You will be required to come to our 
lab for a total of 3 visits to assess your body composition via a DXA scan and skin fold 
assessments and your pain thresholds will be examined by experimentally induced pain 
prior to and following isometric exercising and placing your feet in a cold-water bath. 
The visits will be roughly 30-45 minutes in length for a total time commitment of 2 hrs. 
and 15 min. If you have any questions or would like to participate, please contact me at 
580-318-4151 or Cameron.L.Lohman-1@ou.edu, or Dr. Chris Black, Principal 
Investigator, at 705-255-3750 or cblack@ou.edu. 
All the best, 
Cameron Lohman 
The University of Oklahoma is an equal opportunity institution. IRB 9025,  
 
 
Appendix J: Additional Data Tables 
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